Clinical Trials

Showing 461 - 480 of 512 trials
Title Investigatorsort icon Disease(s)
A Phase I Study of Cabazitaxel in Children and Teens with Persistent Solid Tumors
Relapsed/Refractory
[Protocol 13-021]
Trippett, Tanya
  • Pediatric Brain Tumors
    • CNS Cancer
  • Primary Bone
  • Sarcomas
  • Solid Tumors
A Phase I/II Clinical Study of Vorinostat Plus Etoposide in Pediatric Patients with Refractory Solid Tumors
[Protocol 10-096]
Trippett, Tanya
A Phase I Study of SGN-CD19A in Children and Adults with Persistent B-Cell Acute Lymphoblastic Leukemia or Aggressive Non-Hodgkin Lymphoma
Relapsed/Refractory
[Protocol 13-106]
Trippett, Tanya
  • Leukemia
    • Acute Lymphoblastic Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study of Moxetumomab Pasudotox in Children with Acute Lymphocytic Leukemia or Lymphoblastic B-Cell Lymphoma: the MOXIE Study
Relapsed/Refractory
[Protocol 13-206]
Trippett, Tanya
  • Leukemia
    • Acute Lymphoblastic Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study of Cyclophosphamide, Topotecan, and Bevacizumab in Patients with Relapsed or Refractory Ewing's Sarcoma and Neuroblastoma
Newly Diagnosed & Relapsed/Refractory
[Protocol 11-183]
Trippett, Tanya
  • Neuroblastoma
  • Primary Bone
    • Ewing's Sarcoma
  • Sarcomas
    • Ewing's Sarcoma
    • Soft Tissue Sarcoma
A Phase I/II Study of Brentuximab (SGN-35) in Pediatric Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma or Hodgkin Lymphoma
Relapsed/Refractory
[Protocol 11-210]
Trippett, Tanya
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
A Study of Imaging to Detect HER2 Positive Cancer Cells in Women with Breast Cancer, to Guide the Use of HER2 Targeted Therapies
Newly Diagnosed & Relapsed/Refractory
[Protocol 14-156]
Ulaner, Gary
  • Breast Cancer
FACBC Positron Emission Tomography and Positron Emission Mammography to Evaluate Response to Breast Cancer Chemotherapy
[Protocol 11-177]
Ulaner, Gary
  • Breast Cancer
A Study Assessing Fluorestradiol PET/CT for Imaging Estrogen Receptor Status
Newly Diagnosed & Relapsed/Refractory
[Protocol 13-071]
Ulaner, Gary
  • Breast Cancer
  • Cervical Cancer
  • Ovarian Cancer
Impact of Breast Conservation Surgery on Surgical Outcomes and Cosmetic Appearance in Patients with Multiple Tumors in One Breast
[Protocol 13-023]
Van Zee, Kimberly
  • Breast Cancer
A Phase I Study of LY3023414 in Patients with Advanced Cancer
[Protocol 12-286]
Varghese, Anna
  • Mesothelioma
  • Solid Tumors
A Phase I Study of VS-5584 in Patients with Lymphoma or Advanced Solid Tumors
[Protocol 14-065]
Varghese, Anna
  • Lymphoma
  • Solid Tumors
A Phase I Study of BVD-523 in Patients with Advanced Cancers
[Protocol 13-254]
Varghese, Anna
  • Melanoma
  • Solid Tumors
The Prevention of Delirium and Complications Associated with Surgical Treatments (PODCAST) Clinical Trial
Newly Diagnosed & Relapsed/Refractory
[Protocol 13-240]
Veselis, Robert
  • Psychiatry & Behavioral Sciences
  • Quality of Life
A Phase II Study of Axitinib plus Dalantercept or Placebo for Patients with Metastatic Kidney Cancer
[Protocol 12-255]
Voss, Martin
  • Kidney Cancer
A Phase I Study of INK128 (MLN0128) in Patients with Advanced Kidney, Bladder, or Endometrial Cancer
[Protocol 13-118]
Voss, Martin
  • Bladder Cancer
  • Kidney Cancer
A Phase I Study of Nivolumab in Combination with Sunitinib, Pazopanib, or Ipilimumab in Patients with Metastatic Renal Cell Carcinoma
[Protocol 12-147]
Voss, Martin
  • Kidney Cancer
A Phase I/II Study of Pazopanib plus MK-3475 (Pembrolizumab) in Patients with Previously Untreated, Inoperable Advanced Kidney Cancer
[Protocol 14-074]
Voss, Martin
  • Kidney Cancer
A Phase I Study of Debio1347 in Patients with Advanced Cancers Containing FGFR Alterations
[Protocol 13-131]
Voss, Martin
  • Bladder Cancer
  • Breast Cancer
  • Head & Neck Cancer
  • Lung Cancer, Non-Small Cell
    • Other
  • Lung Cancer, Small Cell
  • Solid Tumors
  • Upper Gastrointestinal
    • Gastric Cancer
  • Uterine (Endometrial) Cancer
A Phase I Study of Mogamulizumab (KW-0761) in Patients with Advanced Solid Tumors
[Protocol 14-135]
Wolchok, Jedd
  • Solid Tumors